FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
125 hedge funds and large institutions have $591M invested in Flexion Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+2
Holders Change %
+1.63%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
25
Increased
53
Reduced
22
Closed
22
Calls
$3.46M
Puts
$4M
Net Calls
-$532K
Net Calls Change
-$1.77M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$20.4M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$18.5M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$17.3M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$17M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$12.7M |
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$7.01M |
| 2 |
GS
Gagnon Securities
New York
|
-$6.94M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.63M |
| 4 |
GA
Gagnon Advisors
New York
|
-$3.39M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.22M |
